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A b s t r a c t Objective: To determine the consistency among the practice guidelines of the
Dutch College of General Practitioners with respect to the use of blood tests.
Methods: The authors evaluated 64 practice guidelines of the Dutch College of General
Practitioners. For each guideline, they analyzed each sentence that contained a reference to a
blood test to determine the clinical situation in which the test should be performed (the
indication) and to determine the tests that should be performed in that situation (the recommended
test). An incomplete recommendation refers to a guideline that mentioned a blood test but did not
identify the indication for that test. An inconsistency refers to the situation in which one guideline
recommended a certain test for a given indication whereas another guideline mentioned the
same indication but did not recommend the same test.
Results: Twenty-seven practice guidelines mentioned blood tests. Of these, three explicitly
recommended not to request blood tests. Five guidelines contained incomplete recommendations,
and the authors encountered two inconsistencies among the guidelines. Twenty-three guidelines
mentioned blood tests and allowed the authors to identify indications and recommended tests.
Conclusion: The identification of indications and recommended tests allows evaluation of
consistency among practice guidelines. Although some incomplete recommendations and
inconsistencies were discovered, the majority of the guidelines provide clear and unambiguous
recommendations for blood-test ordering in primary care.
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To deal with the rapidly expanding amount of medi-
cal knowledge, guidelines are viewed increasingly as
a mechanism for distributing knowledge to practition-
ers.1,2 Governmental agencies and professional organ-
izations are developing clinical practice guidelines. In
the Netherlands, the Dutch College of General Prac-
titioners issues guidelines for the general practitioner.
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These guidelines are published regularly in ‘‘Huisarts
en Wetenschap,’’ the journal of the college. These
guidelines assist general practitioners in dealing with
specific clinical conditions in a primary care setting.
A number of studies have shown that the existence of
guidelines does not necessarily lead to the use of these
guidelines by physicians. Even when authoritative
guidelines are available, changing the behavior of
physicians has proved difficult.3,4 Investigators ac-
knowledge that the implementation of guidelines con-
stitutes an important research area that has to be ad-
dressed.5
One mechanism for implementing guidelines is using
information technology to develop decision support
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systems based on guidelines. Decision support sys-
tems based on guidelines may focus on supporting a
single guideline for a particular disease, e.g., heart
failure, asthma, or diabetes. The objective of the sys-
tem is to help the practitioner in the management of
a particular disease using the appropriate guideline.
Such a system typically covers several aspects of care,
providing recommendations for diagnostic investiga-
tions, selection of treatment, and follow-up. In this ap-
proach, the paper-based guidelines are replaced by
electronic guidelines. Experience, however, has shown
that researchers developing decision support systems
based on a guideline may encounter significant prob-
lems such as inconsistencies in the guideline, inaccu-
rate or incomplete descriptions of terms, ambiguity,
or incompleteness.6–11 This change from paper guide-
lines to a decision support system, therefore, requires
an extensive analysis of the content of the guidelines.
Unlike systems that focus on a single guideline, we
focus on the collection of guidelines issued by the
Dutch College of General Practitioners. Discrepancies
and inconsistencies among different guidelines that
are dealing with similar issues may further aggravate
the problems encountered by developers of systems
based on individual guidelines. Several guidelines, for
example, may refer to the same diagnostic investiga-
tion, disease, or treatment. The guidelines, however,
do not necessarily agree on the recommend course of
action. Given the procedures by which these guide-
lines are developed, such inconsistencies are possible;
the development of a guideline is not just a scientific
endeavor, but the human factor plays an important
role.12
The procedure of creating a guideline consists of four
stages.12 The first stage involves the selection of ap-
propriate topics for new guidelines by an indepen-
dent advisory board. The guidelines are intended for
use by general practitioners; the topics selected and
the level of detail thus reflect practice in primary care.
Although criteria for selecting topics are articulated,
the process of selecting topics is partly subjective. In
the second stage, a small task force consisting of four
to eight general practitioners with special interest and
expertise in the topic of that guideline prepare a draft.
This draft is based on a review of the available liter-
ature and current medical practice. As a result, the
draft reflects not only scientific evidence, but also the
consensus of the task force with respect to appropriate
medical practice in primary care. In the third stage,
this draft is peer-reviewed by a random sample of 50
Dutch general practitioners and a number of special-
ists. The fourth and final stage involves the authori-
zation of the guideline by a board consisting of lead-
ing general practitioners including the chairs of the
university departments of general practice. After au-
thorization, the guideline is published in the journal
of the Dutch general practitioners. This publication
consists of three parts: a brief, algorithmic summary
of the guideline that focuses on the decisions the gen-
eral practitioner has to make; a more detailed descrip-
tion of the guideline itself; and a scientific justification
of the guideline. The brief, algorithmic summary of
the guideline is also distributed as separate card that
can be used during consultations. In addition, teach-
ing material is prepared that can be used for contin-
uing medical education.
Although the available scientific evidence plays an
important role, the Dutch College of General Practi-
tioners acknowledges that each guideline is, to vary-
ing degrees, dependent on the subjective opinions of
the individuals involved in the creation of that guide-
line.12 Each guideline is based on arguments of the
individual members of the task force and subsequent
reviewers. For each guideline, however, different gen-
eral practitioners participate in the task force. The pro-
cess of developing guidelines, therefore, does not
guarantee consistency. To develop a decision support
system that provides the general practitioner with rec-
ommendations based on all the available guidelines,
these guidelines need to be analyzed and evaluated
for inconsistencies within an individual guideline and
for inconsistencies among guidelines. In order to fo-
cus the analysis, we restrict ourselves to the recom-
mendations for blood tests. The choice for recommen-
dations for blood tests is based on previous Dutch
research.
Requesting blood tests is an important aspect of the
health care delivered by the general practitioner in the
Netherlands. Although this proportion is lower than
in many other European countries,13 about 4 percent
of patients’ encounters with Dutch general practition-
ers result in the physician requesting blood tests.14
Physicians’ use of blood tests, however, is not always
appropriate.1,15–19 Dutch investigators report a lack of
general practitioners’ knowledge concerning the in-
dications for blood tests leading to inappropriate and
inadequate use of diagnostic tests.20 The need to im-
prove the use of blood tests, however, is not limited
to the Netherlands. Other investigators argue that im-
proving the quality of blood test ordering deserves
attention.21–23
The objective of this study is to evaluate the guide-
lines of the Dutch College of General Practitioners
with respect to the ordering of blood tests. We want
to determine whether these guidelines provide a con-
sistent base for the development of a decision support
system for blood test ordering.
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Methods
Up to January 1, 1998, the Dutch College of General
Practitioners had published 64 guidelines. The college
regularly updates the guidelines. We analyzed the
most recent version of each guideline that was avail-
able on January 1, 1998. Changes in the guidelines
after this date are not included in this study.
For each of the guidelines, we analyzed each sentence
to determine whether that sentence contained a ref-
erence to blood tests. If the sentence contained a ref-
erence to blood tests, we determined the clinical sit-
uation in which the test should be performed (the
indication) and determined the tests that should be
performed in that situation (the recommended test). An
incomplete recommendation refers to a guideline that
mentioned a blood test, but did not identify in the
guideline the indication for that test, or a guideline
that mentioned an indication for blood tests but did
not provide a further specification of the recom-
mended blood tests. The notion of an incomplete rec-
ommendation is restricted to particular recommen-
dations; we do not determine whether the total set of
recommendations is ‘‘complete’’ in the sense that the
set covers all indications in primary care.
After we identified the indications and recommended
tests in all guidelines, we checked—for each indica-
tion in each guideline—whether another guideline
recommended another test for the same indication. A
inconsistency refers to the situation in which one
guideline recommended a certain test for a given in-
dication whereas another guideline mentioned the
same indication but did not recommend the same test.
Results
Of the 64 guidelines, 27 contained at least one sen-
tence that included a reference to blood tests. Of the
27 guidelines that mentioned blood tests, 3 explicitly
recommended not to request blood tests. The guide-
line ‘‘Sinusitis’’ states that sinusitis itself is not an in-
dication for measurement of the erythrocyte sedimen-
tation rate (ESR),24 the guideline ‘‘Depression’’ states
that depression itself is not an indication for mea-
surement of thyroid-stimulating hormone (TSH) or
thyroxine (T4),25 and the guideline ‘‘Blood tests and
liver disease’’ states that infectious mononucleosis is
not itself an indication for liver function tests.26
Incomplete Recommendations
Of the 27 guidelines containing at least one sentence
that included a reference to blood tests, 5 guidelines
contained incomplete recommendations; that is, a
guideline mentioned a blood test but did not describe
the indication. The guideline ‘‘Imminent miscarriage’’
mentions a possible hemoglobin test but does not
specify which patients are eligible.27 The guideline
‘‘Children with fever’’ states that blood tests are sel-
dom indicated; when blood tests are indicated, and
which tests should be requested, however, are not
specified.28 The guideline ‘‘Problematic alcohol con-
sumption’’ identifies abnormal values of glutamyl-
transferase (gamma-GT), aspartate aminotransferase
(ASAT), and alanine aminotransferase (ALAT) as pos-
sible indicators of alcohol abuse but does not describe
if and when these tests should be performed.29 The
guideline ‘‘Intrauterine device’’ mentions the possi-
bility of elevated erythrocyte sedimentation rate (ESR)
and leukocytosis but does not specify if and when
tests for these should be performed.30 The guideline
‘‘Acne vulgaris’’ states that, prior to treatment with
isotretinoin, liver and kidney functions should be
evaluated; the guideline, however, provides no fur-
ther specification of which tests should be done.31
Indications and Advised Tests
Of the 64 guidelines, 23 mentioned blood tests and
allowed us to identify the indication for those
tests.26,31–52 We distinguish five different categories of
indications. The first category of indications describes
clinical situations in which the general practitioner
considers a diagnosis, the working diagnosis. This
working diagnosis is the most probable diagnosis
based on the patient’s medical history or physical
findings, or both. The physician subsequently uses the
laboratory tests to support or refute that diagnosis. In
total, the guidelines mention 18 working diagnoses.
Table 1 shows the working diagnosis, the recom-
mended tests, and the guideline that makes the rec-
ommendation. In some cases, abnormal results of in-
itial tests should be followed by additional
investigations; for example, an abnormal value for
TSH should be followed by a test for free T4.
The second category of indications describes clinical
situations in which the general practitioner has estab-
lished a diagnosis and uses the laboratory to investi-
gate the underlying pathology that could cause the dis-
ease. The crucial difference with the category working
diagnosis is that in case of underlying pathology the
guideline requires that the physician has already es-
tablished the presence of a specific diagnosis. Given
the presence of this specific diagnosis, the guideline
specifies the evaluation of possible causes. In total, the
guidelines mention ten diagnoses in which underly-
ing pathology needs to be explored. Table 2 shows the
diagnoses, the suspected underlying pathology, the
recommended tests, and the guideline that makes that
recommendation. For example, when the diagnosis
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Table 1 n
Recommended Tests for Each Working Diagnosis
Working Diagnosis Recommended tests Guideline
Alcohol-induced hepatitis
Allergic asthma (adults)
Allergic asthma (children)
ALAT, gamma-GT
Phadiatop,*,† RAST‡
Phadiatop,§ RAST\
Zaat et al., 199226
Geijer et al., 199740
Dirksen et al., 199839
Allergic rhinitis
Diabetes mellitus
Drug-induced liver damage
Phadiatop†
Glucose
ALAT, gamma-GT
Crobach et al., 199534
Cromme et al., 198935
Zaat et al., 199226
Hepatitis A
Hepatitis B
Hepatitis C
Anti-HAV-IgM, anti-HAV-IgG
HBsAg, ALAT, HBcAsg
HCV
Zaat et al., 199226
Zaat et al., 199226
Zaat et al., 199226
Hypercholesterolemia
Hyperthyroidism
Hypothyroidism
Cholesterol
TSH}
TSH}
Van Binsbergen et al., 199149
Pop et al., 199345
Pop et al., 199345
Infectious mononucleosis
Cirrhosis of the liver
Pelvic inflammatory disease
WBC count, WBC differentiation#
Albumin
ESR
Balder et al., 199033
Zaat et al., 199226
Dekker et al., 199537
Prostate cancer
Rheumatoid arthritis
Septic arthritis
PSA
Rheumatoid factors
ESR
Klomp et al., 199441
Schuurman et al., 199447
Bakker et al., 199032
NOTE: ALAT indicates alanine aminotransferase; gamma-GT, gamma-glutamyltransferase; RAST, radioallergosorbent test; anti-HAV-
IgM/IgG, antibody to hepatitis A virus immunoglobulin M or immunoglobulin G; HBsAg, hepatitis B surface antigen; HBcAg,
hepatitis B core antigen; HCV, hepatitis C virus; TSH, thyroid-stimulating hormone; WBC, white blood cell (leukocyte) count; ESR,
erythrocyte sedimentation rate; PSA, prostate-specific antigen.
*Phadiatop is a blood test for screening the most common inhalation allergens.
†If Phadiatop results are positive, RAST-dustmite and, if cat or dog is present as a domestic animal, RAST-cat or RAST-dog.
‡If medical history indicates, RAST-horse or RAST-rodent.
§If Phadiatop results are positive, RAST-dustmite and, if cat, dog, or horse is present as a domestic animal, RAST-cat, RAST-dog, or
RAST-horse.
\If medical history indicates, RAST-rodent.
}If TSH results are positive, free thyroxine (T4) measurement.
#If WBC findings and differentiation are positive, Paul Bunnell (a test to determine the presence of infectious mononucleosis).
transient ischemic attack (TIA) has been established,
the guideline TIA recommends that tests for ESR and
glucose be requested to explore arteritis temporalis
and diabetes mellitus as underlying causes of the TIA.
The third category involves monitoring the course of a
disease. The physician has established the diagnosis
and is monitoring the progression of the disease. In
total, six guidelines mention diagnoses that can be
monitored. Table 3 shows the established diagnosis,
the tests advised to monitor that condition, and the
guideline that makes that recommendation. For ex-
ample, to monitor diabetes mellitus, the guideline ‘‘di-
abetes mellitus’’ recommends that the physician ob-
tain a glucose measurement every three months, and
cholesterol and creatinine measurements annually.
The fourth category of indications describes situations
in which blood tests are used to select appropriate treat-
ment. In these situations, the physician has established
the diagnosis, and the blood tests are used to identify
factors that have a direct bearing on the choice of sub-
sequent treatment. Based on the results of these blood
tests, the guideline specifies the treatment of choice.
In total, seven guidelines identify blood tests that are
used to select treatment. Table 4 shows the established
diagnosis, the factor that is identified, the recom-
mended tests, and the guideline that makes the rec-
ommendation. For example, the guideline ‘‘Choles-
terol’’ recommends in case of hypercholesterolemia
the measurement of high-density lipoprotein choles-
terol and triglycerides to identify lipid metabolism
disorder, in order to select the right therapy.
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Table 2 n
Recommended Tests for the Underlying Disease, for Each Diagnosis
Diagnosis Underlying Disease Recommended Tests Guideline
Angina pectoris Anemia
Hyperthyroidism
Diabetes mellitus
Hypercholesterolemia
Hb
TSH
Glucose
Cholesterol
Rutten et al., 199446
Rutten et al., 199446
Rutten et al., 199446
Rutten et al., 199446
Dementia Infectious diseases
Anemia
Kidney dysfunction
Thyroid disorder
ESR
Hb, MCV, Ht
Creatinine
TSH
De Bruyne et al., 199136
De Bruyne et al., 199136
De Bruyne et al., 199136
De Bruyne et al., 199136
Heart failure Anemia
Hyperthyroidism
Hb
TSH
Walma et al., 199551
Walma et al., 199551
Hypercholesterolemia Hypothyroidism
Diabetes mellitus
Alcohol abuse
Liver disease
TSH
Glucose
ALAT, gamma-GT
ALAT, gamma-GT
Van Binsbergen et al., 199149
Van Binsbergen et al., 199149
Van Binsbergen et al., 199149
Van Binsbergen et al., 199149
Hypertension Primary hyperaldosteronism K Van Binsbergen et al., 199149
Icterus
Icterus gravis
neonatorum
Prehepatic/posthepatic icterus
Hemolytic anemia
Pathologic neonatal icterus
ALAT, total bilirubin, gamma-GT
ALAT, total bilirubin, gamma-GT, Hb
Total bilirubin
Zaat et al. 199226
Zaat et al. 199226
Zaat et al. 199226
Iron therapy-resistant
anemia
Hemoglobinopathia in Negroid,
Mediterranean and Southeast
Asian women
Hb, MCV, serum ferritin Oldenziel et al., 199344
TIA Arteriitis temporalis
Hypercholesterolemia
Diabetes mellitus
ESR
Cholesterol
Glucose
Van Binsbergen et al., 199550
Van Binsbergen et al., 199550
Van Binsbergen et al., 199550
Ulcus cruris Diabetes mellitus Glucose Schweitzer et al., 199148
Vague complaints Infectious diseases
Anemia
Diabetes mellitus
Hyperthyroidism
ESR
Hb
Glucose
TSH
Dinant et al., 199438
Dinant et al., 199438
Dinant et al., 199438
Dinant et al., 199438
NOTE: Hb indicates hemoglobin; TSH, thyroid-stimulating hormone; ESR, erythrocyte sedimentation rate; MCV, mean cell volume;
Ht, hematocrit; ALAT, alanine aminotransferase; gamma-GT, gamma-glutamyltransferase; K, potassium.
The fifth category of indications describes situations
in which blood tests are used to monitor the side effects
of drugs. The guidelines state that for certain drugs,
the physician should monitor the patient for potential
side effects. In some instances, this requires periodic
blood tests. The results of the blood tests might lead
to modification of prescribe dosages or termination of
treatment with that drug. In total, four guidelines
identify blood tests that need to be performed to mon-
itor side effects of drugs. Table 5 shows the drugs in-
volved, the side effects to be monitored, the recom-
mended tests, the frequency of performing these tests,
and the guideline that makes the recommendation.
For example, the guideline ‘‘Acne vulgaris’’ states that
cholesterol and triglycerides need to be measured one
month after isotretinoin treatment is started and sub-
sequently every three months.
Inconsistencies
We encountered two inconsistencies among the guide-
lines. The guideline ‘‘Angina pectoris’’46 showed an
inconsistency with the guideline ‘‘Disorder of the thy-
roid gland.’’45 The guideline ‘‘Shoulder complaints’’32
showed an inconsistency with the guideline ‘‘Rheu-
matoid arthritis.’’47
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Table 3 n
Recommended Tests for Monitoring the Course of Disease, for Each Diagnosis
Diagnosis Recommended tests Guideline
Diabetes mellitus Glucose, cholesterol, creatinine* Cromme et al., 198935
Hepatitis A ALAT† Zaat et al., 199226
Hepatitis B ALAT, HBsAg, HBeAg‡ Zaat et al., 199226
Hypercholesterolemia Cholesterol§ Van Binsbergen et al., 199149
Hyperthyroidism Free T4\
TSH, Free T4}
Pop et al., 199345
Pop et al., 199345
Pregnancy Hb, blood type, TPHA, HBsAg, IgG antirubella# Oldenziel et al., 199344
Rheumatoid arthritis Hb, MCV** Schuurman et al., 199447
NOTE: ALAT indicates alanine aminotransferase; HBsAg, hepatitis B surface antigen; HBeAg, hepatitis B early antigen; T4, thyroxine;
TSH, thyroid-stimulating hormone; Hb, hemoglobin; TPHA, Treponema pallidum hemagglutination; IgG, immunoglobulin G; MCV,
mean cell volume.
*Fasting glucose measurement every three months; cholesterol and creatinine measurements once a year.
†ALAT measurement every three weeks.
‡ALAT measurement every three weeks; HBsAg and HBeAg measurements after four and eight weeks.
§Cholesterol measurement six months after the start of therapy, followed by yearly evaluation.
\Free T4 measurement every six weeks until euthyroidism is achieved; subsequently, every three months.
}Free T4 measurement six weeks after every change of medication; if euthyroidism is achieved, every three months during the first
year; subsequently, once a year.
#IgG antirubella measurement at the first pregnancy; Hb, HBsAg, and TPHA measurements every pregnancy.
**Hb measurements twice a year; MCV measurement only in case of positive Hb results.
Table 4 n
Recommended Tests for Selecting Appropriate Treatment, for Each Diagnosis
Diagnosis Factor Recommended Tests Guideline
Constitutional eczema Food allergy RAST-foodmix Lucassen et al., 199542
Food hypersensitivity in infants Serious reaction at food provocation RAST-5 Lucassen et al., 199542
Hypercholesterolemia Elevated triglycerides
Elevated HDL
Triglycerides
HDL-cholesterol
Van Binsbergen et al., 199149
Van Binsbergen et al., 199149
Hypertension With risk factors Glucose, cholesterol,
creatinine
Van Binsbergen et al., 199149
Impeded urination in elderly men Kidney dysfunction Creatinine Klomp et al., 199441
Vaginal bleeding Anemia Hb Meijer et al., 199243
NOTE: RAST indicates radioallergosorbent test; HDL, high-density lipoprotein; Hb, hemoglobin.
According to the guideline ‘‘Angina pectoris,’’ the
general practitioner should, in case of angina pectoris
in combination with tachycardia, request TSH testing
to evaluate hyperthyroidism. The guideline ‘‘Disorder
of the thyroid gland’’ describes when a TSH value
should be obtained; patients with angina pectoris and
tachycardia, however, are not mentioned.
The guideline ‘‘Shoulder complaints’’ states that in-
sufficient effect of initial treatment is a reason for
blood tests; an elevated ESR is an indicator for rheu-
matoid or septic arthritis. In the guideline ‘‘Rheuma-
toid arthritis,’’ however, the list of advised tests for
excluding or confirming rheumatoid arthritis does not
include ESR.
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Table 5 n
Recommended Tests for Measuring Side Effects of Therapy
Therapy Side Effect Recommended Tests Guideline
Isotretinoin Hyperlipidemia Cholesterol, triglycerides* Blom et al., 199131
HMG-coenzyme inhibitors Liver dysfunction
Muscular pain
ALAT†
CK‡
Van Binsbergen et al., 199149
Van Binsbergen et al., 199149
Ace-inhibitors, digoxine, diuretics Not specified K, Creatinine, Na§ Walma et al., 199551
Sulfasalazine Anemia
Liver dysfunction
Agranulocytosis
Not specified
Hb\
ALAT, gamma-GT\
Thrombocytes, WBC, WBC-differentiation\
Creatinine\
Schuurman et al., 199447
Schuurman et al., 199447
Schuurman et al., 199447
Schuurman et al., 199447
NOTE: HMG-coenzyme inhibitors indicates hydroxymethylglutaryl-CoA reductase inhibitors; ALAT, alanine aminotransferase; CK,
creatine kinase; K, potassium; Na, sodium; Hb, hemoglobin; gamma-GT, gamma-glutamyltransferase; WBC, white blood cell (leu-
kocyte) count.
*Baseline measurement of triglycerides at the start of treatment; subsequently, after four weeks, followed by evaluation every three
months.
†Baseline measurement of ALAT at the start of treatment; subsequently, after four weeks.
‡Creatine kinase measurement after four weeks of therapy (only when the patient complains of muscular pain).
§Sodium measurement once every six months.
\Hemoglobin measurement every two weeks during the first three months of therapy; subsequently, every month.
Discussion
The objective of this study was to identify in all guide-
lines issued by Dutch College of General Practitioners
the specific recommendations for using the laboratory
and to analyze these recommendations for inconsis-
tencies. The underlying reason for such an analysis
was the desire to build a decision support system that
would help general practitioners in using these guide-
lines.
Guidelines
Our study shows that the guidelines contain specific
and detailed recommendations for ordering blood
tests. Given the fact that previous studies have re-
ported a lack of general practitioners’ knowledge con-
cerning indications for tests,18,20 the guidelines could
provide needed support. These recommendations,
however, are scattered throughout many different
guidelines (a total of 27 of the 64 practice guidelines).
In addition, the guidelines may overlap. For example,
the guideline ‘‘Problematic alcohol consumption’’
states that increased levels of gamma-GT, ASAT, and
ALAT are possible indicators of excessive alcohol
abuse; the guideline does not describe if or when tests
for these substances should be performed. The guide-
line ‘‘Blood tests and liver disease’’ specifies that if the
practitioner suspects alcohol-induced hepatitis, ALAT
and gamma-GT tests should be performed; the ASAT
is in this guideline considered redundant. We con-
clude that the currently available paper-based guide-
lines require the general practitioner to spend time
and effort locating and interpreting the recommen-
dations for blood tests.
Two inconsistencies were found among the guidelines
with respect to the use of the laboratory. A possible
explanation for these inconsistencies could be the fact
that, although the guidelines are revised regularly, not
all guidelines are revised at the same time. As a result,
one guideline may already reflect changed medical
understanding, whereas another, possibly due for re-
vision in the near future, does not yet reflect this
change. Given that inconsistencies were found, we
recommend that organizations that maintain a set of
guidelines should make available to physicians a list
of known inconsistencies among those guidelines.
Our analysis shows that, with respect to the use of
the laboratory tests, five guidelines contained incom-
plete recommendations. Ambiguity or lack of clarity
in guidelines could create uncertainty on the part of
the general practitioner that in turn could stimulate
the ordering of unnecessary blood tests. Guideline
developers should, therefore, avoid incomplete rec-
ommendations in guidelines. Twenty-three guide-
lines, however, did contain well-defined and specific
recommendations for the use of the laboratory. Given
that other investigators have reported a lack of knowl-
edge about test ordering, we believe that applying the
guidelines in general practice would result in im-
proved test ordering by general practitioners.
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Decision Support System
From the perspective of medical informatics, the ob-
jective of our study was to identify the specific rec-
ommendations for using the laboratory, and analyze
them for inconsistencies. From this perspective we
conclude that the guidelines contain concrete and spe-
cific recommendations and that only few inconsisten-
cies were found. Moreover, the study shows that iden-
tifying the indication for requesting blood test is one
possible method for analyzing the guidelines. The in-
dication for blood tests is the specific question of the
physician to which obtaining the test will provide a
(partial) answer. We conclude that the recommenda-
tions for blood tests in the guidelines of the Dutch
College of General Practitioners are focused on de-
scribing what tests are necessary in the context of a
given indication.
For researchers in medical informatics, this notion of
the indication as the physician’s question has signifi-
cant consequences for designing a decision support
system. Given the concept of the indication, the de-
signer faces a choice. The first alternative is, given the
patient’s symptoms, that the system identifies the in-
dication for blood tests. The second alternative is,
given the indication, the system selects the appropri-
ate tests. For the general practitioner, these two ap-
proaches result in two very different systems. If the
objective is to support the identification of the indi-
cation, the decision support system will request de-
tailed information about the patient’s condition.
Based on these findings, the system will generate pos-
sible indications, select among these, and prepare a
recommendation. If the objective of the system is to
select the appropriate test given the indication, the
system will ask the physician questions about the in-
dication; the translation of the patient’s condition to a
specific indication is left to the general practitioner.
The system builder thus has to determine whether de-
cision support is based on the patient’s symptoms or
on the physician’s indications.
We have decided to build a system that requests from
the physician the indication. As a result, the system is
driven by questions related to the objectives of the
physician. The system does not ask detailed questions
about the symptoms or complaints of the patient. The
downside of this approach is that the system does not
support the physician in establishing the appropriate
indication based on the complaints of the patient. This
decision to leave the identification of the initial work-
ing diagnosis to the general practitioner is based
partly on the fact that the guidelines provide recom-
mendations on the level of indication. It is also based
partly on our assertion that physicians especially are
able to translate the often-complex presentation of pa-
tients’ complaints into well-defined indications. In ad-
dition, a general practitioner in the Netherlands sees
a very different patient population when compared
with a specialist working in a hospital, since the prev-
alence of diseases is different. The patient’s com-
plaints presented in general practice might well result
in selection of a different working diagnosis than in a
hospital setting. Computers are able to deal only with
those parts of the patient–physician encounter that
can be expressed as objective facts and numbers; as a
result, decision support systems can only deal with
only a very limited segment of reality. Other investi-
gators have noted that decision support systems tend
to ignore the intellect of physicians53 and leave the
practitioner with a sense of losing control.54 We be-
lieve that in the initial interpretation of a patient’s
symptoms, the role of a decision support system
should be very limited.
Further research is needed to show whether decision
support based on the guidelines is acceptable and ef-
fective.
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